Position in AMGN
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$2,702,863
+$2,365,439 QoQ
Shares Held
7,464
+678.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#1,118
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Charles Schwab Trust Co holds $19,134,040 across 8 Drug Manufacturers - General names. AMGN ranks #3 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
31,692 | $7,974,974 | |
| 2 | JNJ |
Johnson & Johnson
|
15,446 | $3,922,820 | |
| 3 | AMGN |
Amgen Inc
This page
|
7,464 | $2,702,863 | |
| 4 | LLY |
ELI LILLY & Co
|
1,832 | $2,197,355 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,250 | $1,060,125 | |
| 6 | BIIB |
Biogen Inc.
|
3,101 | $670,002 | |
| 7 | PFE |
Pfizer Inc
|
16,129 | $388,386 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,775 | $217,515 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,702,863 | 7,464 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $337,424 | 959 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $304,725 | 931 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $443,336 | 1,571 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $330,026 | 1,182 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $358,594 | 1,151 | Shares | Sole | 2025-04-10 | |
| 2024-09-30 | $202,670 | 629 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $540,226 | 1,729 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $404,871 | 1,424 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $415,612 | 1,443 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $387,820 | 1,443 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $342,576 | 1,543 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $373,020 | 1,543 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $405,253 | 1,543 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $375,741 | 1,667 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $437,210 | 1,797 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $403,113 | 1,667 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $381,774 | 1,697 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $360,867 | 1,697 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $415,837 | 1,706 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $391,378 | 1,573 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $463,978 | 2,018 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $501,711 | 1,974 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $447,898 | 1,899 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $384,984 | 1,899 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||